del Campo, Marta http://orcid.org/0000-0003-2808-3699
Vermunt, Lisa
Peeters, Carel F. W.
Sieben, Anne
Hok-A-Hin, Yanaika S. http://orcid.org/0000-0001-9713-116X
Lleó, Alberto
Alcolea, Daniel http://orcid.org/0000-0002-3819-3245
van Nee, Mirrelijn
Engelborghs, Sebastiaan http://orcid.org/0000-0003-0304-9785
van Alphen, Juliette L.
Arezoumandan, Sanaz
Chen-Plotkin, Alice
Irwin, David J.
van der Flier, Wiesje M. http://orcid.org/0000-0001-8766-6224
Lemstra, Afina W.
Teunissen, Charlotte E. http://orcid.org/0000-0002-4061-0837
Funding for this research was provided by:
Alzheimer Nederland (WE.03-2018-05)
W. Garfield Weston Foundation (NR170065)
Article History
Received: 12 December 2022
Accepted: 22 August 2023
First Online: 13 September 2023
Competing interests
: M.C. has been an invited speaker at Eisai, is an associate editor at Alzheimer´s Research & Therapy and has been an invited writer for Springer Healthcare. L.V. received a grant for CORAL consortium by Olink. D.I. is a Scientific Advisory Board Member for Denali Therapeutics. D.A. participated in advisory boards from Fujirebio-Europe and Roche Diagnostics and received speaker honoraria from Fujirebio-Europe, Roche Diagnostics, Nutricia, Krka Farmacéutica S.L., Zambon S.A.U. and Esteve Pharmaceuticals S.A. D.A., and A.L. declare a filed patent application (Title: Markers of synaptopathy in neurodegenerative disease; Applicant: Fundació Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau, Inventors: Olivia BELBIN; Alberto LLEÓ; Alejandro BAYÉS; Juan FORTEA; Daniel ALCOLEA; Application number: PCT/EP2019/056535; International Publication Number: WO 2019/175379 A1; Current status: Active. Licensed to ADx Neurociences NV (Ghent, Belgium); This patent is not related to any specific aspect of the current manuscript). W.F. has performed contract research for Biogen MA Inc, and Boehringer Ingelheim. W.F. has been an invited speaker at Boehringer Ingelheim, Biogen MA Inc, Danone, Eisai, WebMD Neurology (Medscape), Springer Healthcare. W.F. is consultant to Oxford Health Policy Forum CIC, Roche, and Biogen MA Inc. WF participated in advisory boards of Biogen MA Inc and Roche. All funding is paid to her institution. W.F. is a member of the steering committee of PAVE, and Think Brain Health. WF was associate editor of Alzheimer, Research & Therapy in 2020/2021. W.F. is an associate editor at Brain. C.E.T. has a collaboration contract with ADx Neurosciences, Quanterix and Eli Lilly, performed contract research or received grants from AC-Immune, Axon Neurosciences, Bioconnect, Bioorchestra, Brainstorm Therapeutics, Celgene, EIP Pharma, Eisai, Grifols, Novo Nordisk, PeopleBio, Roche, Toyama, Vivoryon. She serves on editorial boards of Medidact Neurologie/Springer, Alzheimer Research and Therapy, Neurology: Neuroimmunology & Neuroinflammation, and is editor of a Neuromethods book Springer. She had speaker contracts for Roche, Grifols, Novo Nordisk. The rest of the authors declare no competing interest.